MA54959A - Composés, compositions et procédés - Google Patents

Composés, compositions et procédés

Info

Publication number
MA54959A
MA54959A MA054959A MA54959A MA54959A MA 54959 A MA54959 A MA 54959A MA 054959 A MA054959 A MA 054959A MA 54959 A MA54959 A MA 54959A MA 54959 A MA54959 A MA 54959A
Authority
MA
Morocco
Prior art keywords
compositions
compounds
methods
Prior art date
Application number
MA054959A
Other languages
English (en)
Inventor
Ii Robert A Craig
Vicente Fidalgo Javier De
Jianwen A Feng
Maksim Osipov
Arun Thottumkara
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Publication of MA54959A publication Critical patent/MA54959A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
MA054959A 2019-02-13 2020-02-12 Composés, compositions et procédés MA54959A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962805273P 2019-02-13 2019-02-13

Publications (1)

Publication Number Publication Date
MA54959A true MA54959A (fr) 2021-12-22

Family

ID=72045626

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054959A MA54959A (fr) 2019-02-13 2020-02-12 Composés, compositions et procédés

Country Status (4)

Country Link
US (1) US20220177438A1 (fr)
EP (1) EP3924341A4 (fr)
MA (1) MA54959A (fr)
WO (1) WO2020167994A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001352A (es) 2017-08-09 2020-03-20 Denali Therapeutics Inc Compuestos, composiciones y metodos.
BR112020011914A2 (pt) 2017-12-13 2020-11-24 Praxis Biotech LLC inibidores de via de resposta de tensão integrada
BR112020023115A2 (pt) 2018-06-05 2021-02-02 Praxis Biotech LLC inibidores da via integrada de resposta a tensão
CR20210426A (es) 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos
JP2022536663A (ja) 2019-06-12 2022-08-18 プラクシス バイオテック エルエルシー 統合的ストレス応答経路のモジュレーター
IL296220A (en) 2020-03-11 2022-11-01 Evotec Int Gmbh Modulators for an integrated stress response pathway
KR20230110510A (ko) 2020-10-22 2023-07-24 에보텍 인터내셔널 게엠베하 통합 스트레스 반응 경로의 조절제
JP2023546224A (ja) 2020-10-22 2023-11-01 エヴォテック・インターナショナル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 統合ストレス応答経路のモジュレーター
WO2022084448A1 (fr) 2020-10-22 2022-04-28 Evotec International Gmbh Modulateurs de la voie de réponse intégrée au stress

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429207B1 (en) * 1997-11-21 2002-08-06 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
WO2013120940A2 (fr) * 2012-02-14 2013-08-22 Syngenta Participations Ag Nouveaux composés
ES2764660T3 (es) * 2014-12-16 2020-06-04 Axovant Sciences Gmbh Compuestos de amida de quinuclidina sustituida geminal como agonistas de receptores alfa-7 nicotínicos de acetilcolina
GB201506894D0 (en) * 2015-04-23 2015-06-10 Galapagos Nv Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
TW201808914A (zh) * 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
MX2020001352A (es) * 2017-08-09 2020-03-20 Denali Therapeutics Inc Compuestos, composiciones y metodos.

Also Published As

Publication number Publication date
EP3924341A1 (fr) 2021-12-22
EP3924341A4 (fr) 2022-11-02
US20220177438A1 (en) 2022-06-09
WO2020167994A1 (fr) 2020-08-20

Similar Documents

Publication Publication Date Title
MA54953A (fr) Composés, compositions et procédés
MA49858A (fr) Composés, compositions et procédés
MA54959A (fr) Composés, compositions et procédés
MA50063A (fr) Composés, compositions et procédés
MA54875A (fr) Compositions oligonucléotidiques et procédés associés
MA52489A (fr) Nouveaux composés
MA43380A (fr) Récepteurs chimériques modifiés et compositions et procédés associés
MA52896A (fr) Composés inhibiteurs de vmat2, compositions et méthodes associées
MA51669A (fr) Composés
MA41677A (fr) Composés alpha-cinnamide et compositions comme inhibiteurs de hdac8
MA56032A (fr) Composés, compositions et procédés d'utilisation
MA50175A (fr) Formulation de valbenazine à dosage élevé et compositions, procédés et kits associés
DK3702023T3 (da) Skråtstillet blandeapparat
MA55624A (fr) Composés, compositions et procédés
KR20220035398A (ko) 신규 화합물 및 그 용도
MA45857A (fr) Composés et compositions, et utilisations associées
DK3705835T3 (da) Kobling
MA52648A (fr) Agonistes de ppar, composés, compositions pharmaceutiques et leurs procédés d'utilisation
DK3747512T3 (da) Forbedret trampolin
MA48942A (fr) Composés thérapeutiques, compositions et procédés d'utilisation associés
MA45795A (fr) Composés et compositions, et utilisations associées
MA52946A (fr) Composés
DK3840596T3 (da) Sammensætning
DK3738452T3 (da) Fordamper
MA54946A (fr) Procédés et composés